4-碘-3-甲氧基苯甲酸甲酯 | 35387-92-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-碘-3-甲氧基苯甲酸甲酯
• 中文别名: 3-甲氧基-4-碘苯甲酸甲酯
• 英文名称: methyl 4-iodo-3-methoxybenzoate
• CAS: 35387-92-9
• 化学式: C₉H₉IO₃
• 分子量: 292.073
• InChiKey: GALFBPQYWHBOPA-UHFFFAOYSA-N

物化性质

• 熔点：
  48-49 °C
• 沸点：
  324.3±32.0 °C(Predicted)
• 密度：
  1.684±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2918990090
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  存储条件：室温下避光、干燥密封保存。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Methyl 4-iodo-3-methoxybenzoate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Methyl 4-iodo-3-methoxybenzoate
CAS number: 35387-92-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H9IO3
Molecular weight: 292.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen Iodide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-碘-3-甲氧基苯甲酸甲酯 在 三溴化硼 作用下， 以 二氯甲烷 为溶剂， 反应 4.0h， 生成 4、.4'-二羧基联苯-.2、.2'-二羧基联苯
  参考文献：
  名称：

  Control of framework interpenetration for in situ modified hydroxyl functionalised IRMOFs

  摘要：

  通过密切控制反应条件，可以合成具有互穿和非互穿结构的相纯结晶多孔金属有机框架材料 [Zn4O(L)3]。在特定条件下，这些反应发生的同时，位于有机链节上的掩蔽醇会发生脱保护反应，从而在框架内产生可触及的 "金属结合 "官能团。

  DOI：

  10.1039/c2cc35565e
• 作为产物：
  描述：

  5-甲基-2-硝基苯甲醚 在 palladium on activated charcoal potassium permanganate 、 硫酸 、 三氟化硼 、 氢气 、 碳酸氢钠 、 potassium iodide 、 sodium nitrite 作用下， 以 乙醇 、 二氯甲烷 、 水 为溶剂， 反应 30.0h， 生成 4-碘-3-甲氧基苯甲酸甲酯
  参考文献：
  名称：

  Towards New Iron(III) Chelators: Synthesis and Complexing Ability of a Water-Soluble Tripodal Ligand Based on 2,2′-Dihydroxybiphenyl Subunits

  摘要：

  DOI：

  10.1002/(sici)1099-0682(199805)1998:5<613::aid-ejic613>3.0.co;2-l

文献信息

• Ring strain and total syntheses of modified macrocycles of the isoplagiochin type
  作者：Andreas Speicher、Timo Backes、Kerstin Hesidens、Jürgen Kolz

  DOI：10.3762/bjoc.5.71

  日期：——

  Macrocycles of the bisbibenzyl-type are natural products that are found exclusively in bryophytes (liverworts). The molecular framework of the subtype “isoplagiochin” is of substantial structural interest because of the chirality of the entire molecule, which arises from two biaryl axes in combination with two helical two-carbon units in a cyclic arrangement. From a structural as well as a synthetic point of view we report on the total synthesis of compounds which possess more rigid two-carbon biaryl bridges like stilbene (E or Z) or even tolane moieties which were introduced starting with a Sonogashira protocol. The McMurry method proved to be a powerful tool for the cyclization to these considerably ring-strained macrocycles.

  双苯基苯并型大环化合物是一类仅在苔藓植物（地钱藓）中发现的天然产物。亚型“异悬叶素”的分子框架具有重要的结构意义，因为整个分子的手性是由两个联合的联苯轴和两个螺旋的双碳单元在循环排列中产生的。从结构和合成的角度来看，我们报道了具有更刚性的双碳联苯桥的化合物的全合成，如苯乙烯（E或Z）或甚至是通过Sonogashira协议引入的甲苯基团。 McMurry方法被证明是将这些具有相当环张力的大环化合物环化的强大工具。
• Three sra topological lanthanide–organic frameworks built from 2,2′-dimethoxy-4,4′-biphenyldicarboxylic acid
  作者：Xin Wang、Jie Zhao、Yan Zhao、Heng Xu、Xuan Shen、Dun-Ru Zhu、Su Jing

  DOI：10.1039/c5dt00602c

  日期：——

  The first neutral 3D sra-LOF built from a 1D inorganic rod-shaped chain [Ln(CO₂)₂(HCO₂)]_n (Ln = Eu, Gd, Dy) was synthesized.

  第一个由一维无机棒状链[Ln(CO₂)₂(HCO₂)]_n（Ln = Eu, Gd, Dy）构建的中性3D sra-LOF已合成。
• Syntheses of Chlorinated Bisbibenzyls from Bryophytes
  作者：Andreas Speicher、Jürgen Kolz、Rufino Paulino Sambanje

  DOI：10.1055/s-2002-35629

  日期：——

  Chlorinated bisbibenzyls of the isoplagiochin type detected in different bryophyte species were synthesized by an efficient and flexible unit construction system making extensive use of Suzuki and Wittig protocols.

  在检测到的不同苔藓植物中的异型二苯并双芴类的氯化物，是通过一种高效的、灵活的单元构建系统合成的，该系统广泛采用了铃木和维蒂希方案。
• IRAK DEGRADERS AND USES THEREOF
  申请人：Kymera Therapeutics, Inc.

  公开号：US20190192668A1

  公开（公告）日：2019-06-27

  The present invention provides compounds, compositions thereof, and methods of using the same.

  本发明提供了化合物、其组合物以及使用这些化合物的方法。
• [EN] ARYLOXYACETYLINDOLES AND ANALOGS AS ANTIBIOTIC TOLERANCE INHIBITORS<br/>[FR] ARYLOXYACÉTYLINDOLES ET ANALOGUES EN TANT QU'INHIBITEURS DE TOLÉRANCE AUX ANTIBIOTIQUES
  申请人：SPERO THERAPEUTICS INC

  公开号：WO2016112088A1

  公开（公告）日：2016-07-14

  The disclosure provides compounds and pharmaceutical compositions of aryloxyacetylindoles compounds and analogs useful for treating chronic and acute bacterial infections. Certain of the compounds are compounds of general Formula (I) (I) or a pharmaceutically acceptable salt or prodrug thereof. Certain compounds of this disclosure are MvfR inhibitors. MvfR inhibitors reduce the formation of antibiotic tolerant bacterial strains and are useful for treating Gram-negative bacterial infections and reducing the virulence of Pseudomonas aeruginosa. Methods of treating bacterial infections in a subject, including Pseudomonas aeruginosa infections, are also provided by the disclosure.

  该披露提供了芳基氧乙酰基吲哚化合物及类似物的化合物和药物组合物，用于治疗慢性和急性细菌感染。其中某些化合物是一般式(I)（I）的化合物或其药用可接受的盐或前药。该披露的某些化合物是MvfR抑制剂。MvfR抑制剂减少抗生素耐药细菌菌株的形成，对治疗革兰氏阴性细菌感染和减少铜绿假单胞菌的毒力有用。该披露还提供了治疗受试者细菌感染的方法，包括铜绿假单胞菌感染。